A complete application in a minute
Tailored resume and cover letter, ready to send.
PT Taisho Pharmaceutical Indonesia seeks a Hospital Account Section Head to drive hospital sales, oversee key accounts and distributors, and lead a team to meet business targets.
The role requires developing strategic plans for hospital/institutional channels, managing agreements/tenders, and coordinating with Marketing, Medical, Regulatory, and Sales Operations to support hospital engagement initiatives.
Drives hospital sales, manages key accounts and distributors, ensures compliance, and leads the team to meet business targets.
Oversee sales performance, distribution, and sales productivity across hospital and institutional channels.
Develop and implement business plans and strategies for hospital and institutional accounts.
Monitor and manage hospital agreements, product listings (SKU), formulary listings, and tender activities.
Conduct business reviews with key hospital management (KPDM) and business consultants to identify growth opportunities and drive hospital sales.
Plan and execute engagement activities with Key Opinion Leaders (KOLs), including doctors and pharmacists.
Collaborate with distributors and their subsidiaries to ensure alignment with company strategies, policies, and business objectives.
Work closely with Marketing, Medical, Regulatory, and Sales Operations teams to support hospital and HCP engagement activities, including events, sponsorships, and other promotional initiatives.
Initiate business improvement initiatives to support business expansion while ensuring compliance with applicable regulations.
Bachelor’s degree in any major
Minimum of 3 years of experience in the hospital channel.
Have strong negotiations with hospital management and the doctor.
Have strong entrepreneurial skills in planning and reporting.
Have a good command of computers.
Pharmaceuticals, Biotechnology & Medical Devices 101-1,000 employees
Taisho Pharmaceutical Indonesia is the subsidiary of Taisho Pharmaceutical Co., Ltd., Japan - the number one over-the-counter medications company in Japan.
In Indonesia, Taisho Pharmaceutical has been operating since the end of 2009 after acquiring Bristol-Myers Squibb. Our main brands are Counterpain, Tempra, Theragran-M, Kenacort, Myco-Z and Mycostatin OS (Oral Suspension).